Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)

OBJECTIVES: To assess the safety and therapeutic effects of allogeneic human dental pulp stem cells (DPSCs) in treating severe pneumonia caused by COVID-19. TRIAL DESIGN: This is a single centre, two arm ratio 1:1, triple blinded, randomized, placebo-controlled, parallel group, clinical trial. PARTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qingsong, Wang, Hua, Xia, Xia, Zhou, Chenliang, Liu, Zhiming, Xia, Zun-en, Zhang, Zhan, Zhao, Yang, Yehenala, Jun, Wang, Si, Zhou, Gangqiao, Hu, Ke, Wu, Bin, Wu, Chu-Tse, Wang, Songling, He, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290137/
https://www.ncbi.nlm.nih.gov/pubmed/32532356
http://dx.doi.org/10.1186/s13063-020-04380-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290137/
https://www.ncbi.nlm.nih.gov/pubmed/32532356
http://dx.doi.org/10.1186/s13063-020-04380-5

Ejemplares similares